BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 18718554)

  • 1. Flow-cytometric analysis of in vitro micronucleus formation: comparative studies with WIL2-NS human lymphoblastoid and L5178Y mouse lymphoma cell lines.
    Laingam S; Froscio SM; Humpage AR
    Mutat Res; 2008 Oct; 656(1-2):19-26. PubMed ID: 18718554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro micronucleus scoring by flow cytometry: differential staining of micronuclei versus apoptotic and necrotic chromatin enhances assay reliability.
    Avlasevich SL; Bryce SM; Cairns SE; Dertinger SD
    Environ Mol Mutagen; 2006 Jan; 47(1):56-66. PubMed ID: 16180205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evaluation of a flow cytometric in vitro micronucleus assay in CHO-K1 cells: a reliable platform that detects micronuclei and discriminates apoptotic bodies.
    Shi J; Bezabhie R; Szkudlinska A
    Mutagenesis; 2010 Jan; 25(1):33-40. PubMed ID: 19843589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using CTLL-2 and CTLL-2 bcl2 cells to avoid interference by apoptosis in the in vitro micronucleus test.
    Meintières S; Biola A; Pallardy M; Marzin D
    Environ Mol Mutagen; 2003; 41(1):14-27. PubMed ID: 12552588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interlaboratory evaluation of a flow cytometric, high content in vitro micronucleus assay.
    Bryce SM; Avlasevich SL; Bemis JC; Lukamowicz M; Elhajouji A; Van Goethem F; De Boeck M; Beerens D; Aerts H; Van Gompel J; Collins JE; Ellis PC; White AT; Lynch AM; Dertinger SD
    Mutat Res; 2008 Feb; 650(2):181-95. PubMed ID: 18182318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Litron In Vitro MicroFlow Kit for the flow cytometric enumeration of micronuclei (MN) in mammalian cells.
    Collins JE; Ellis PC; White AT; Booth AE; Moore CE; Burman M; Rees RW; Lynch AM
    Mutat Res; 2008 Jun; 654(1):76-81. PubMed ID: 18567533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric 96-well microplate-based in vitro micronucleus assay with human TK6 cells: protocol optimization and transferability assessment.
    Bryce SM; Avlasevich SL; Bemis JC; Tate M; Walmsley RM; Saad F; Van Dijck K; De Boeck M; Van Goethem F; Lukamowicz-Rajska M; Elhajouji A; Dertinger SD
    Environ Mol Mutagen; 2013 Apr; 54(3):180-94. PubMed ID: 23447390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between p53 status, apoptosis and induction of micronuclei in different human and mouse cell lines in vitro: Implications for improving existing assays.
    Whitwell J; Smith R; Jenner K; Lyon H; Wood D; Clements J; Aschcroft-Hawley K; Gollapudi B; Kirkland D; Lorge E; Pfuhler S; Tanir JY; Thybaud V
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Aug; 789-790():7-27. PubMed ID: 26232254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different cytotoxicity measurements for the in vitro micronucleus assay using L5178Y and TK6 cells in support of OECD draft Test Guideline 487.
    Lorge E
    Mutat Res; 2010 Oct; 702(2):199-207. PubMed ID: 20298804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric analysis of micronucleated reticulocytes: Time- and dose-dependent response of known mutagens in mice, using multiple blood sampling.
    De Boeck M; van der Leede BJ; Van Goethem F; De Smedt A; Steemans M; Lampo A; Vanparys P
    Environ Mol Mutagen; 2005 Jul; 46(1):30-42. PubMed ID: 15880423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic toxicity assessment: employing the best science for human safety evaluation. Part II: Performances of the in vitro micronucleus test compared to the mouse lymphoma assay and the in vitro chromosome aberration assay.
    Lorge E; Lambert C; Gervais V; Becourt-Lhote N; Delongeas JL; Claude N
    Toxicol Sci; 2007 Apr; 96(2):214-7. PubMed ID: 17192442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of four different treatment conditions of extended exposure in the in vitro micronucleus assay using TK6 lymphoblastoid cells.
    Hashimoto K; Nakajima Y; Matsumura S; Chatani F
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):28-36. PubMed ID: 20800082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of caspase activity on micronuclei detection: a possible role for caspase-3 in micronucleation.
    Decordier I; Cundari E; Kirsch-Volders M
    Mutagenesis; 2005 May; 20(3):173-9. PubMed ID: 15817572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo erythrocyte micronucleus assay III. Validation and regulatory acceptance of automated scoring and the use of rat peripheral blood reticulocytes, with discussion of non-hematopoietic target cells and a single dose-level limit test.
    Hayashi M; MacGregor JT; Gatehouse DG; Blakey DH; Dertinger SD; Abramsson-Zetterberg L; Krishna G; Morita T; Russo A; Asano N; Suzuki H; Ohyama W; Gibson D;
    Mutat Res; 2007 Feb; 627(1):10-30. PubMed ID: 17157053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro micronucleus assay scored by flow cytometry provides a comprehensive evaluation of cytogenetic damage and cytotoxicity.
    Bryce SM; Bemis JC; Avlasevich SL; Dertinger SD
    Mutat Res; 2007 Jun; 630(1-2):78-91. PubMed ID: 17434794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interlaboratory validation of a CD71-based flow cytometric method (Microflow) for the scoring of micronucleated reticulocytes in mouse peripheral blood.
    Torous DK; Hall NE; Illi-Love AH; Diehl MS; Cederbrant K; Sandelin K; Pontén I; Bolcsfoldi G; Ferguson LR; Pearson A; Majeska JB; Tarca JP; Hynes GM; Lynch AM; McNamee JP; Bellier PV; Parenteau M; Blakey D; Bayley J; van der Leede BJ; Vanparys P; Harbach PR; Zhao S; Filipunas AL; Johnson CW; Tometsko CR; Dertinger SD
    Environ Mol Mutagen; 2005; 45(1):44-55. PubMed ID: 15605355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SFTG international collaborative study on in vitro micronucleus test V. Using L5178Y cells.
    Oliver J; Meunier JR; Awogi T; Elhajouji A; Ouldelhkim MC; Bichet N; Thybaud V; Lorenzon G; Marzin D; Lorge E
    Mutat Res; 2006 Aug; 607(1):125-52. PubMed ID: 16797225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of in vitro micronucleus and gene mutation assay results for p53-competent versus p53-deficient human lymphoblastoid cells.
    Honma M; Hayashi M
    Environ Mol Mutagen; 2011 Jun; 52(5):373-84. PubMed ID: 20963812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro primary human lymphocyte flow cytometry based micronucleus assay: simultaneous assessment of cell proliferation, apoptosis and MN frequency.
    Lukamowicz M; Kirsch-Volders M; Suter W; Elhajouji A
    Mutagenesis; 2011 Nov; 26(6):763-70. PubMed ID: 21791709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytosine arabinoside, vinblastine, 5-fluorouracil and 2-aminoanthracene testing in the in vitro micronucleus assay with L5178Y mouse lymphoma cells at Sanofi Aventis, with different cytotoxicity measurements, in support of the draft OECD Test Guideline on In Vitro Mammalian Cell Micronucleus Test.
    Cariou O; Laroche-Prigent N; Ledieu S; Guizon I; Paillard F; Thybaud V
    Mutat Res; 2010 Oct; 702(2):148-56. PubMed ID: 20398790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.